Profile of male Brazilian injecting drug users who have sex with men

Cadernos de Saude Publica

Volumn 22, Issue 4, 2006, Pages 849-860

  Ferreira, Aline Dayrell ^a   Caiaffa, Waleska Teixeira ^a   Bastos, Francisco I ^b   Mingoti, Sueli Aparecida ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Acquired Immunodeficiency Syndrome; Male Homosexuality; Needle Sharing; Sexual Behavior

Indexed keywords

EID: 33646246147     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2006000400023     Document Type: Article

References (35)

1. Backmund M, Meyer K, Henkel C, Reimer J, Wachtler M, Schutz CG. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users. Eur Addict Res 2005; 11:138-44.
2. Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 2001; 161:1281-8.
3. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health 2003; 80 (4 Suppl 3):iii7-14.
4. Joint United Nations Programme on HIV/AIDS/World Health Organization. AIDS epidemic update: December 2004. http://www.unaids.org/wad2004/EPI_1204_pdf_en/Chapter0-1_ intro_en.pdf (accessed on 15/Jan/2005).
5. Catania JA, Osmond D, Stall RD, Pollack L, Paul J, Blower S, et al. The continuing HIV epidemic among men who have sex with men. Am J Public Health 2001; 91:907-14.
6. Clatts MC, Goldsamt LA, Yi H. Drug and sexual risk in four men who have sex with men populations: evidence for a sustained HIV epidemic in New York City. J Urban Health 2005; 82 Suppl 1:i9-17.
7. Weber AE, Chan K, George C, Hogg RS, Remis RS, Martindale S, et al. Risk factors associated with HIV infection among young gay and bisexual men in Canada. J Acquir Immune Defic Syndr 2001; 28:81-8.
8. Clatts MC, Goldsamt LA, Neaigus A, Welle DL. The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research. J Urban Health 2003; 80 Suppl 3:iii26-39.
9. Boily MC, Bastos FI, Desai K, Masse B. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models. Sex Transm Dis 2004; 31:100-13.
10. Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, Gibson S, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health 2002; 92:388-94.
11. Wolitski RJ, Valdiserri RO, Denning PH, Levine WC. Are we headed for a resurgence of the HIV epidemic among men who have sex with men? Am J Public Health 2001; 91:883-8.
12. Bluthenthal RN, Kral AH, Gee L, Lorvick J, Moore L, Seal K, et al. Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. J Acquir Immune Defic Syndr 2001; 28:264-9.
13. Morin SM, Vernon K, Harcourt J, Steward WT, Volk J, Riess TH, et al. Why HIV infections have increased among men who have sex with men and what to do about it: findings from California focus groups. AIDS Behav 2003; 7:353-62.
14. Courtenay-Quirk C, Wolitski RJ, Hoff C, Parsons JT. Interests in HIV prevention topics of HIV-seropositive men who have sex with men. AIDS Educ Prev 2003; 15:401-12.
15. Thiede H, Valleroy LA, Mackellar DA, Celentano DD, Ford WL, Hangan H, et al. Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. Am J Public Health 2003; 93:1915-21.
16. Colfax G, Coates TJ, Husnik MJ, Huang Y, Buchbinder S, Koblin B, et al. Longitudinal patterns of methamphetamine, popper (Amyl Nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. J Urban Health 2005; 82 Suppl 1:i62-9.
17. O'Connell JM, Lampinen TM, Weber AE, Chan K, Miller ML, Schechter MT, et al. Sexual risk profile of young men in Vancouver, British Columbia, who have sex with men and inject drugs. AIDS Behav 2004; 8:17-23.
18. Tyndall MW, Patrick D, Spittal P, Li K, O'Shaughnessy MV, Schechter MT. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect 2002; 78 Suppl 1:i170-5.
19. Halkitis PN, Green KA, Mourgues P. Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: findings from Project BUMPS. J Urban Health 2005; 82 Suppl 1:i18-25.
20. Banta-Green C, Goldbaum G, Kingston S, Golden M, Harruff R, Logan BK. Epidemiology of MDMA and associated club drugs in the Seattle area. Subst Use Misuse 2005; 40:1295-315.
21. Hacker MA, Friedman SR, Telles PR, Teixeira SL, Bongertz V, Morgado MG, et al. The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil. Subst Use Misuse 2005; 40:99-123.
22. Caiaffa WT. Projeto AjUDE-Brasil: avaliação epidemiológica dos usuários de drogas injetáveis dos projetos de redução de danos apoiados pela CN-DST/AIDS. Série Avaliação 6. 2001. http://www.aids.gov.br (accessed on 20/Sep/2003).
23. World Health Organization/Joint United Nations Programme on HIV/AIDS. Working group on global HIV/AIDS and STI surveillance. Second generation HIV surveillance: the next decade. Geneva: World Health Organization/Joint United Nations Programme on HIV/AIDS; 2000.
24. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons; 1989.
25. Hogg R, Weber A, Chan K, Martindale S, Cook D, Miller M, et al. Increasing incidence of HIV infections among young gay and bisexual men in Vancouver. AIDS 2001; 15:1321-22.
26. Kral AH, Bluthentahal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001; 357:1397-401.
27. Maslow CB, Friedman SR, Perlis TE, Rockwell R, Des Jarlis DC. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health 2002; 92:382-4.
28. McCoy CB, Metsch LR, Comerford M, Zhao W, Coltes AJ, Messiah SE. Trends of HIV risk behaviors in a cohort of injecting drug users and their sex partners in Miami, Florida, 1988-1998. AIDS Behav 2005; 9:187-99.
29. Vlahov D, Celentano DD. Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death. Cad Saúde Pública 2006; 22:705-31.
30. Patterson TL, Shirley JS, Zians JK, Strathdee SA. Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use. J Urban Health 2005; 82 Suppl 1:i120-6.
31. Valleroy LA, Mackellar DA, Karon JM, Rosen DH, McFarland W, Shehan DA, et al. HIV prevalence and associated risks in young men who have sex with men. JAMA 2000; 284:198-204.
32. Weber AE, Craib KJP, Chan K, Martindale S, Miller ML, Cook DA, et al. Determinants of HIV serconversion in an era of increasing HIV infection among young gay and bisexual men. AIDS 2003; 17:774-7.
33. Roxburgh A, Degenhardt L, Breen C. Drug use and risk behaviours among injecting drug users: a comparison between sex workers and non-sex workers in Sydney, Australia. Harm Reduct J 2005, 2:1-9.
34. Kral AH, Lovrvick J, Ciccarone D, Wenger L, Gee L, Martinez A, et al. HIV prevalence and risk behaviors among men who have sex with men and injected drugs in San Francisco. J Urban Health 2005; 82 Suppl 1:i43-50.
35. Fuller CM, Absalon J, Ompad DC, Nash D, Koblin B, Blaney S, et al. A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000-2003. J Urban Health 2005; 82 Suppl 1:i51-61.